Clinical trial
Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia
NCT04738396 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 29, 2020
- Completion date
- December 8, 2022
- Enrollment
- 52 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac pacing, pacing therapy